COVID-19 in Patients with Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization

INTRODUCTION: SARS-CoV-2 causes more severe symptoms in most chronic diseases, and rheumatic disease is no exception. This study aims to investigate whether there is an association between the use of immunomodulatory medications, including conventional disease-modifying agents (csDMARDs), glucocorti...

Descripción completa

Detalles Bibliográficos
Autores principales: Azizi, Hossein, Karimi, Hanie, Kazemi, Mahdi, Rezaei, Somaye Sadat, Parsaei, Amirhossein, Aghaali, Mohammad, Vafaeimanesh, Jamshid, Torabi, Pouya, Amini, Behnam, Masoumi, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716495/
https://www.ncbi.nlm.nih.gov/pubmed/36475037
http://dx.doi.org/10.1007/s40744-022-00508-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716495/
https://www.ncbi.nlm.nih.gov/pubmed/36475037
http://dx.doi.org/10.1007/s40744-022-00508-y

Ejemplares similares